In the healthcare system, certainty saves lives. Yet, in recent years, global supply chains have demonstrated their fragility. The COVID-19 pandemic was the clearest stress test, revealing that even critical medical supplies, such as wound care products can be delayed, rationed, or entirely unavailable when the world’s manufacturing and logistics networks falter.
For hospitals and procurement managers, both in the US and UK, the lesson was clear: supply chain resiliency is no longer optional, but a critical purchasing factor.
Global supply fragility in wound care
The statistics detailing this are stark. In 2021, a significant number of US hospitals reported shortages of essential items, sterile wound dressings to personal protection equipment. In some instances, freight costs for medical goods surged, while shipping lead times stretched from days to weeks.
These were not just operational headaches. They translate directly to postponed surgeries, disrupted wound care schedules, and increased risk to patients.
In the UK, the NHS Supply Chain faced similar challenges, with procurement teams working to secure continuity, while balancing cost-effectiveness and evidence-based product selection.
A shift toward local & regional sourcing
In the US in 2023, a Premier Inc. survey found 78% of health systems plan to increase domestic or near-shore sourcing within the next three years to reduce exposure to global transport disruptions. In the UK, NHS procurement leaders are also evaluating supply chain risk alongside clinical evidence, compliance, and whole life cost savings, not simply the unit price. This shift reflects a strategic redefinition of value: resilience, regulatory alignment, and supply continuity now rank alongside cost in procurement decisions.
Why a localised supply chain can strengthen wound care delivery
Local suppliers offer measurable advantages for wound care product manufacturers:
The advantages of local wound care supply chains
- Reduced lead times – Regional manufacturing can cut delivery lead times by between 40 and 60%. This means less emergency stock holding and fewer instances of dangerously low inventory.
- Agility during demand spikes – Local suppliers can rapidly scale production to meet surges in demand – vital for high turnover consumables, where shortages can compromise infection control and healing outcomes.
- Regulatory compliance and predictability – In the US, the FDA’s Unique Device Identification (UDI) requirements and state-specific healthcare regulations are easier to navigate with domestic suppliers. In the UK, proximity enables faster engagement between suppliers and NHS clinical procurement specialists.
- Enhanced collaboration and innovation – Shorter distances enable closer relationships between manufacturers and suppliers, leading to faster problem-solving, more effective product development, and quicker prototyping.
- Sustainability & economic impact – Reduced transport distances cut carbon emissions, while sourcing locally supports job creation and economic growth in the region.
Dual sourcing
Hospitals in the US and UK are adopting dual sourcing strategies, splitting procurement between global and local suppliers to ensure redundancy. In the US, regional suppliers are integrated into state stockpile programmes, while in the UK, NHS Supply Chain leverages framework agreements and regional networks to maintain contingency options.
Evidence-led wound care procurement
In the NHS, procurement decisions are shaped by clinical evidence, cost-effectiveness, and clinician engagement. Product selection is often weighted across multiple criteria, including price, clinical excellence, training, and after-sales support, to ensure patient outcomes are not compromised by cost-only decisions.
Wound care formulary management, as discussed by NHS procurement specialists, demonstrates how standardisation and evidence-based evaluation reduce waste, ensure consistency, and improve patient care.
From reactive to proactive procurement
The events of the last few years have shifted hospital procurement from a cost-driven exercise to a risk-managed strategy. Localisation is not isolationism; it is about creating a balanced, resilient wound care supply ecosystem where patient care is protected from the shocks of a volatile global marketplace.
In healthcare, the cost of a delayed delivery cannot be measured solely in monetary terms; it must be measured in outcomes.
PolarSeal® strengthens the chain
As a manufacturer with proven design agility, regional compliance expertise, and the capability to scale production for urgent demand, PolarSeal® is well-positioned to deliver not just wound care products but reliability.
Our advanced wound care solutions and medical components are produced with the same precision for both local and international markets – ensuring that when a hospital or health care facility needs supplies, they receive them without delay, and with the full compliance that modern healthcare demands. For more information on our portfolio of services, contact our team today.
